Journal Overview

The Jentashapir Journal of Cellular and Molecular Biology (JJCMB) is an open-access, peer-reviewed journal dedicated to advancing research in cellular and molecular biology. It publishes a variety of article types, including original research, reviews, meta-analyses, short communications, and case reports, covering topics such as genomics, proteomics, bioinformatics, molecular medicine, and disease diagnostics. JJCMB follows a “Per-Article Continuous” publishing model and ensures long-term digital preservation through Portico. The journal maintains a strict ethical publishing policy and does not charge submission or processing fees, providing free and global access to its content.

Jentashapir Journal of Cellular and Molecular Biology
ISSN: e: 2717-2724
Frequency: quarterly

Abstracted/Indexed: Electronic Journal of Library | Scientific Information Database (SID) | ISC | World Cat | Ricest | ROAD, more
Scope: All fields of Cellular and Molecular Biology, more
COPE member: Since 2017
Copyright Policy: CC BY-NC 4.0
Publishing Access: Open Access (Platinum Open Access: APC covered by the sponsor) 
Peer Review Policy: Double-Blind Peer Review System Open Peer Review

Recent Articles

6 articles
2025-03-31
vol. 16 , issue 1

Explore the latest articles published in this journal for impactful research and the newest advancements in the field.

22
Jan
2025
Jentashapir J Cell Mol Biol
12
Jan
2025
Jentashapir J Cell Mol Biol

Comparison the Hippocampal Stathmin and TFEB Proteins Level in Animal Models of PTSD and Depression

Erfan Kavoosi ORCID , Solmaz Khalifeh ORCID , Mohammad Nasehi ORCID , Fatemeh Rohallah ORCID , Afshin Kheradmand ORCID , Farzaneh Nazari-Serenjeh ORCID *
|
Final Published
13
Feb
2025
Jentashapir J Cell Mol Biol

Innovative Platforms in Regenerative Medicine: Bridging Research and Clinical Solutions

Seyedeh Neda Jalali ORCID , Zahra Fathi, Sohameh Mohebbi ORCID *
|
Uncorrected Proof scheduled for 16 (1)
22
Jan
2025
Jentashapir J Cell Mol Biol
24
Dec
2024
Jentashapir J Cell Mol Biol

From the Shadow of Virus Infection to Darkness of the Diabetes

Majid Komijani ORCID * , Amir Jalali ORCID , Gasan Hadi Diabil, Sarah Abulmahdi Zaghira, Mehdi Nodeh Farahani
|
Final Published
04
Jan
2025
Jentashapir J Cell Mol Biol

HL-10 Peptide as a Potential Therapeutic Agent for Cervical SiHa Cancer Cells

Zahra Setayesh-Mehr * , Leila Vafadar Ghasemi
|
Final Published

Journal Metrics

Discover our most recent insights and updates.
Submit to First Decision (Days):
16
Accept to Publication (Days):
17
Acceptance Rate (%) :
35.48
Article Processing Charges:
Free
Share it!

An official COPE member

Author Services

Brieflands Author Services

Contact Us!